title: How can registries contribute to the development and evaluation of CNS therapeutics?
abstract: This article is based on the proceedings from a workshop held during the Autumn 2011 International Society for CNS Clinical Trials and Methodology (ISCTM) Conference in Amelia Island, Florida. The goal of the workshop was to establish preliminary steps in determining whether and how patient registries can augment clinical trials in the field of central nervous system therapeutics. Participants in the workshop first defined several different types of registries and then created a list of questions that should be addressed in order to determine how registries might be used. The workshop concluded with discussion on logistical and practical considerations regarding use of patient registries.
authors.affiliation: Ms. Severe is a research consultant in Rockville, Maryland, and Dr. Stemhagen is with United Biosource Corp. in Bethesda, Maryland.
authors.forename: Joanne B
authors.initials: JB
authors.lastname: Severe
authors.forename: Annette
authors.initials: A
authors.lastname: Stemhagen
keywords: Registries; augment clinical trials; clinical trials; registry data